Search by Drug Name or NDC
NDC 53002-1306-01 Clonazepam 0.5 mg/1 Details
Clonazepam 0.5 mg/1
Clonazepam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is CLONAZEPAM.
MedlinePlus Drug Summary
Clonazepam is used alone or in combination with other medications to control certain types of seizures. It is also used to relieve panic attacks (sudden, unexpected attacks of extreme fear and worry about these attacks). Clonazepam is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain.
Related Packages: 53002-1306-01Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Clonazepam
Product Information
| NDC | 53002-1306 |
|---|---|
| Product ID | 53002-1306_39281c03-3d7c-499d-bc00-4bacc96c09a4 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Clonazepam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clonazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | CLONAZEPAM |
| Labeler Name | RPK Pharmaceuticals, Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA074569 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 53002-1306-01 (53002130601)
| NDC Package Code | 53002-1306-1 |
|---|---|
| Billing NDC | 53002130601 |
| Package | 10 TABLET in 1 BOTTLE (53002-1306-1) |
| Marketing Start Date | 2017-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |